Dianthus Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(C)(4)
Dianthus Therapeutics granted inducement awards to five newly-hired non-executive employees approved by its independent Compensation Committee. The awards consist of non-qualified stock options to purchase an aggregate of 58,000 shares of common stock with an exercise price of $90.21 per share.
Key figures
- Term years
- 10
- Exercise price
- 90.21
- Options granted
- 58000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.